Skip to main content

Table 1 Comparison of general data of patients in three groups

From: Characteristics of glucose metabolism indexes and continuous glucose monitoring system (CGMS) in patients with insulinoma

Variables

Insulinoma group (44)

Hypoglycemia group (26)

Control group (31)

P value

Sex (M/F)

16/28

14/12

15/16

 

Age

50.59 ± 13.2

55.64 ± 12.6

53.23 ± 11.9

0.302

Course

6.43 ± 6.94*

1.62 ± 2.24

0.006

BMI

28.44 ± 4.49*

24.54 ± 3.75

22.7 ± 2.6

0.019

SBP

129.32 ± 14.35

138.0 ± 14.21

133.0 ± 14.18

0.11

DBP

80.64 ± 10.45

77.91 ± 8.32

78.0 ± 7.45

0.458

UA

303.02 ± 63.77

273.87 ± 82.9

282.32 ± 9.52

0.30

TG

1.41 ± 1.05

1.20 ± 0.50

1.15 ± 0.87

0.55

CHO

4.16 ± 0.92

4.16 ± 0.80

4.46 ± 0.8

0.99

HDL

1.16 ± 0.41

1.30 ± 0.55

1.41 ± 0.61

0.46

LDL

2.46 ± 0.8

2.4 ± 0.68

2.43 ± 0.78

0.85

  1. BMI Body Mass Index, SBP systolic blood pressure, DBP diastolic blood pressure, UA uric acid, TG triglycerides, CHO total cholesterol, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol
  2. *P < 0.05